BT-7480 by Bicycle Therapeutics for Solid Tumor: Likelihood of Approval

BT-7480 is under clinical development by Bicycle Therapeutics and currently in Phase II for Solid Tumor.

Procept wins FDA clearance for updated prostate surgery robot

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Procept Biorobotics has received 510(k)

August 22, 2024

An offer you can’t refuse: Democrats and Republicans trade barbs over incoming drug price negotiations

Quotes from the popular mafia movie “The Godfather” featured prominently in Republican comments at a House hearing yesterday on incoming drug price negotiations (or offers

September 22, 2023

U.S. maternal mortality rate dips, but will the trend continue?

After years on the rise, the U.S. maternal mortality rate decreased in 2022, new government data show. But maternal health experts warn there’s no reason

May 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.